Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients.
about
Negative Allosteric Modulators of Metabotropic Glutamate Receptors Subtype 5 in Addiction: a Therapeutic WindowBrain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial.mGlu5 negative allosteric modulators: a patent review (2013 - 2016).Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease.Metabotropic Glutamate Receptor 5 as a Target for the Treatment of Depression and Smoking: Robust Preclinical Data but Inconclusive Clinical Efficacy.Effects of mGluR5 Antagonists on Parkinson's Patients With L-Dopa-Induced Dyskinesia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
P2860
Q26775243-E2ED691B-9EEC-40E3-B443-12F59B3AC0FEQ30833645-0EA9446A-9682-424F-96B4-F8C79F1FAC78Q38375701-074742AC-3B30-4F2C-8FCF-818A6C496CD6Q39076410-83A13C66-B9DF-40EF-AC4A-0FDC5C4B619BQ52562719-E10C61FD-5AAE-433D-9496-9832AF196FF8Q52600080-D6EDF975-B267-4754-8641-D64B7458A7B1Q57113178-DEFE90EA-A8D1-46CC-840B-B6C223238A25
P2860
Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mavoglurant (AFQ056) in combin ...... Parkinson's disease patients.
@ast
Mavoglurant (AFQ056) in combin ...... Parkinson's disease patients.
@en
Mavoglurant
@nl
type
label
Mavoglurant (AFQ056) in combin ...... Parkinson's disease patients.
@ast
Mavoglurant (AFQ056) in combin ...... Parkinson's disease patients.
@en
Mavoglurant
@nl
prefLabel
Mavoglurant (AFQ056) in combin ...... Parkinson's disease patients.
@ast
Mavoglurant (AFQ056) in combin ...... Parkinson's disease patients.
@en
Mavoglurant
@nl
P2093
P2860
P1476
Mavoglurant (AFQ056) in combin ...... Parkinson's disease patients.
@en
P2093
Christopher Kenney
Joseph Mostillo
Martin Merschhemke
Nalina Dronamraju
Rajeev Kumar
P2860
P356
10.3109/00207454.2013.841685
P577
2013-09-06T00:00:00Z